Showing results (201-210 of 299) with videos related to
Sort By:
Pageof 30
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2023
Body Composition Changes Over the Menopausal Transition in Women With and Without Human Immunodeficiency VirusRebecca A Abelman, Thuy Trang J Nguyen, Yifei Ma, et al.Journal of Neurovirology|December 17, 2013
Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV StudyDeborah R Gustafson, Michelle M Mielke, Phyllis C Tien, et al.American Journal of Obstetrics and Gynecology|March 5, 2011
Preeclampsia and the risk of large-for-gestational-age infantsCamille E Powe, Jeffrey Ecker, Sarosh Rana, et al.The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsiaRavi Thadhani, Walter P Mutter, Myles Wolf, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|February 28, 2013
Postnatal outcome of fetuses with the prenatal diagnosis of gastroschisisSara M Durfee, Carol B Benson, Sonia R Adams, et al.BMJ Open|July 2, 2017
Predicting death over 8 years in a prospective cohort of HIV-infected women: the Women's Interagency HIV StudyDeborah R Gustafson, Qiuhu Shi, Susan Holman, et al.AIDS (London, England)|December 4, 2008
Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected womenNancy A Hessol, Elizabeth A Holly, Jimmy T Efird, et al.Journal of the National Cancer Institute|July 22, 2004
Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive womenLinda Ahdieh-Grant, Rui Li, Alexandra M Levine, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapyMonica Gandhi, Niloufar Ameli, Peter Bacchetti, et al.Plos One|April 9, 2010
Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markersBulbulgul Aumakhan, Charlotte A Gaydos, Thomas C Quinn, et al.Pageof 30